Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Toxins Année : 2019

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls

Résumé

Pain currently represents the most common symptom for which medical attention is sought by patients. The available treatments have limited effectiveness and significant side-effects. In addition, most often, the duration of analgesia is short. Today, the handling of pain remains a major challenge. One promising alternative for the discovery of novel potent analgesics is to take inspiration from Mother Nature; in this context, the detailed investigation of the intriguing analgesia implemented in Buruli ulcer, an infectious disease caused by the bacterium Mycobacterium ulcerans and characterized by painless ulcerative lesions, seems particularly promising. More precisely, in this disease, the painless skin ulcers are caused by mycolactone, a polyketide lactone exotoxin. In fact, mycolactone exerts a wide range of effects on the host, besides being responsible for analgesia, as it has been shown notably to modulate the immune response or to provoke apoptosis. Several cellular mechanisms and different targets have been proposed to account for the analgesic effect of the toxin, such as nerve degeneration, the inhibition of inflammatory mediators and the activation of angiotensin II receptor 2. In this review, we discuss the current knowledge in the field, highlighting possible controversies. We first discuss the different pain-mimicking experimental models that were used to study the effect of mycolactone. We then detail the different variants of mycolactone that were used in such models. Overall, based on the results and the discussions, we conclude that the development of mycolactone-derived molecules can represent very promising perspectives for new analgesic drugs, which could be effective for specific pain indications. Key Contribution: This review develops arguments and issues around the development of new potent analgesic drugs derived from mycolactone, a toxin secreted by Mycobacterium ulcerans. To this end, the various modes of action of the toxin potentially underlying its analgesic properties are detailed and discussed in the context of various pain models-also concerning different variants of mycolactone.

Domaines

Cancer
Fichier principal
Vignette du fichier
Marsollier2019Eq6.pdf (3.21 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-02284632 , version 1 (12-09-2019)

Licence

Paternité

Identifiants

Citer

Marie-Line Reynaert, Denis Dupoiron, Edouard Yeramian, Laurent C Marsollier, Priscille Brodin. Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls. Toxins, 2019, 11 (9), pp.516. ⟨10.3390/toxins11090516⟩. ⟨inserm-02284632⟩
88 Consultations
84 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More